science
Small Trial Tests Interleukin-6 Blocker for Depression
A pilot study examined whether an anti-inflammatory drug could reduce symptoms in people with depression. The placebo-controlled randomized trial involved a small number of participants.
May 20, 5:24 PM·1m read1 source
ER
rnz.co.nzAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
A small pilot study tested whether an interleukin-6 blocker, an anti-inflammatory drug, could affect symptoms of depression. The trial was placebo-controlled and randomized. Researchers reported that the approach might be possible based on early results.
The trial used a placebo group for comparison.
It was described as a pilot study with a limited number of participants. Further research would be needed to assess whether the findings hold in larger groups.
Transparency
How sources framed this
ER
ER
Single source — no framing comparison available.
CorroborationModerate · 1 source
